Rituximab has now been listed on the Pharmaceutical Benefits Scheme.

Recommendations on the use of a 3rd Primary Dose of COVID-19 Vaccinations for People Severely Immunocompromised

A Parliamentary Inquiry has commenced into new drugs and novel medical technologies.

The MAA has written in detail to Health Minister Hunt drawing to his attention the potential benefits of making Rituximab available via the PBS.

An unfortunate media release occurred in July this year.